Autoinflammatory diseases in dermatology: DITRA and CAMPS.

Kazumitsu Sugiura
Kazumitsu Sugiura
Nagoya University Graduate School of Medicine

Nihon Rinsho Meneki Gakkai Kaishi 2017 ;40(3):169-173

Department of Dermatology, Fujita Health University School of Medicine.

Deficiency of interleukin thirty-six receptor antagonist (DITRA) and CARD14 mediated psoriasis (CAMPS) are autoinflammatory diseases in dermatology. The causative genes of DITRA and CMAPS have been identified recently. In this paper, IL36RN and CARD14, the causative gene for DITRA and CAMPS, respectively were explained. In addition, clinical features and therapies for generalized pustular psoriasis not associated with psoriasis vulgaris (GPP without PsV), and pityriasis rubra pilaris type V (PRP type V) were described. GPP without PsV and PRP type V are representative diseases of DITRA and CAMPS, respectively.

Download full-text PDF

Source Listing
October 2017
6 Reads

Publication Analysis

Top Keywords

ditra camps
prp type
diseases dermatology
gpp psv
autoinflammatory diseases
features therapies
clinical features
therapies generalized
generalized pustular
pustular psoriasis
addition clinical
explained addition
il36rn card14
paper il36rn
card14 causative
gene ditra
psoriasis associated
camps explained
identified paper

Similar Publications

The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.

J Dermatol Sci 2014 Jun 5;74(3):187-92. Epub 2014 Mar 5.

Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Electronic address:

Generalized pustular psoriasis (GPP) is often present in patients with existing or prior psoriasis vulgaris (PV; "GPP with PV"). However, cases of GPP have been known to arise without a history of PV ("GPP alone"). There has long been debate over whether GPP alone and GPP with PV are distinct subtypes that are etiologically different from each other. Read More

View Article
June 2014

CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.

J Dermatol 2016 Feb 1;43(2):187-9. Epub 2015 Jul 1.

Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Some familial cases of pityriasis rubra pilaris (PRP) have the CARD14 gene mutations that are also detected in familial psoriasis vulgaris. However, genotype-phenotype correlation in these two entities is poorly understood. Here, we report a case of PRP with a new mutation in CARD14. Read More

View Article
February 2016

Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.

J Invest Dermatol 2015 Dec 23;135(12):2964-2970. Epub 2015 Jul 23.

St John's Institute of Dermatology, King's College London, London, UK. Electronic address:

Caspase recruitment family member 14 (CARD14, also known as CARMA2), is a scaffold protein that mediates NF-κB signal transduction in skin keratinocytes. Gain-of-function CARD14 mutations have been documented in familial forms of psoriasis vulgaris (PV) and pityriasis rubra pilaris (PRP). More recent investigations have also implicated CARD14 in the pathogenesis of pustular psoriasis. Read More

View Article
December 2015

Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.

JAMA Dermatol 2017 Jan;153(1):66-70

Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Importance: We found CARD14 mutations (2 de novo novel mutations and another previously reported mutation) in 3 of 3 patients with pityriasis rubra pilaris (PRP) type V, but not in patients with PRP of other types. Our findings, combined with the published literature, suggest that type V PRP, both familial and sporadic, can be caused by CARD14 mutations. Detailed clinical observation revealed that all 3 patients displayed unique patchy macular brown hyperpigmentation. Read More

View Article
January 2017